Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 526 (2) , 276-283
- https://doi.org/10.1016/0006-8993(90)91232-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Binding sites for 125I-cholecystokinin in primate spinal cord are of the CCK-A subclassNeuroscience Letters, 1988
- Nucleotide binding proteins in signal transduction and diseaseTrends in Neurosciences, 1987
- Brain CCK receptors: Species differences in regional distribution and selectivityPeptides, 1986
- The Effects of Cholecystokinin‐8 in the Nucleus Tractus SolitariusAnnals of the New York Academy of Sciences, 1985
- Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrinPeptides, 1983
- Proglumide: Selective Antagonism of Excitatory Effects of Cholecystokinin in Central Nervous SystemScience, 1983
- Distribution of Cholecystokinin‐Like Peptides in the Human BrainJournal of Neurochemistry, 1982
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Immunochemical evidence of cholecystokinin-like peptides in brainNature, 1976